
CBI Files Case Against UK Firm, Former Directors in USD 10 Million Exim Bank Fraud
What Happened?
The CBI has registered a case involving a USD 10 million fraud linked to India Exim Bank, a UK firm, and its former directors. Allegations include siphoning off project funds.
Key points
- The CBI filed the case based on a complaint from G Selva Kumar of India Exim Bank.
- The bank claims a loss of USD 10 million, which was classified as a non-performing asset in September 2014.
- Hanjer Biotech (Erith) Ltd, a UK firm, and its former directors are named in the FIR.
- The loan was approved in 2012 for a recycling project, but machinery was never supplied.
- Funds were allegedly diverted to related parties, including Hume Synthesis.
- The account was later classified as fraud under Reserve Bank of India guidelines.
Key insights
- The case highlights potential vulnerabilities in the loan approval process at banks.
- It may lead to increased scrutiny of foreign firms operating in India.
- The outcome could affect future lending practices by India Exim Bank.
Why it matters
This case could impact the reputation of the involved firms and the banking sector's integrity.
Entities
Source
India Today


